• Explore /
  • Poster
  • / Impact of adjuvant trastuzumab on outcomes of HER2-positive breast cancer patients treated with HER2-targeted therapy in the metastatic setting.

Impact of adjuvant trastuzumab on outcomes of HER2-positive breast cancer patients treated with HER2-targeted therapy in the metastatic setting.

Abstract Poster

Authors

Rashmi Murthy

Rashmi Krishna Murthy

University of Texas M. D. Anderson Cancer Center, Houston, TX

Rashmi Krishna Murthy , Ankur Varma , Priyankana Mishra , Kenneth R. Hess , Elliana J. Young , James L. Murray , Kimberly Higginbotham Koenig , Marjorie C. Green , Stacy L. Moulder , Amal Melhem-Bertrandt , Daniel J. Booser , Vicente Valero , Gabriel N. Hortobagyi , Francisco J. Esteva

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2012 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Breast Cancer - HER2/ER

Track

Breast Cancer

Sub Track

HER2+

Citation

J Clin Oncol 30, 2012 (suppl; abstr 527)

DOI

10.1200/jco.2012.30.15_suppl.527

Abstract #

527

Poster Bd #

17

Abstract Disclosures

Similar Posters

First Author: Zhonghui Ou

First Author: Erica Michelle Stringer-Reasor

First Author: Sandra M. Swain

First Author: Bora Lim